One the biggest advocates of buy and hold investing is legendary investor Warren Buffett. In the past, the Oracle of Omaha has famously quipped that his favourite holding period is "forever." And given the success he has had over the last six decades, he could be onto something!
Mr Buffett clearly also has a penchant for blue chip shares rather than risky small caps. Countless blue chips have graced his portfolio through the years and can be found in it today.
With that in mind, listed below are two buy-rated blue chip shares that could be the sort of investments that Buffett makes. Here's what experts are saying about them:
CSL Limited (ASX: CSL)
The first blue chip share to consider is CSL. It is one of the world's largest biotechnology companies and regarded by many as the highest quality company on the Australian share market. It has consistently grown its sales and earnings at a solid rate for well over a decade and has been tipped to continue this positive form in the future.
This is thanks to its leading therapies, growing plasma collection network, the acquisition of Vifor Pharma, and its burgeoning research and development pipeline. This pipeline contains a number of therapies that have the potential to generate billions of dollars in sales over the next decade if their trials are successful.
The team at Citi is very positive on CSL. It has a buy rating and $340.00 price target on the company's shares.
Goodman Group (ASX: GMG)
Another blue chip ASX share that Buffett could be a fan of is Goodman Group. It is an integrated commercial and industrial property group that owns, develops, and manages industrial real estate across the globe.
Goodman has been growing at a solid rate over the last decade thanks to its exposure to growing markets such as ecommerce. This has resulted in strong demand from fellow blue chip customers such as Amazon, Coles Group Ltd (ASX: COL) and Walmart.
And with this strong demand unabating, Goodman appears well positioned for sustainable growth over the 2020s.
Goldman Sachs is bullish on Goodman's outlook. So much so, it has a buy rating and $25.40 price target on its shares.
